Shares of Palatin Technologies, Inc. (OTCMKTS:PTNT – Get Free Report) crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $20.95 and traded as high as $24.12. Palatin Technologies shares last traded at $24.12, with a volume of 15 shares trading hands.
Palatin Technologies Trading Up 0.9%
The firm has a market capitalization of $976,800.00, a P/E ratio of -15.75 and a beta of 1.64. The business’s 50 day simple moving average is $24.47 and its two-hundred day simple moving average is $21.08.
About Palatin Technologies
Palatin Technologies, Inc is a biopharmaceutical company focused on developing medicines that target the melanocortin receptor system, a group of receptors involved in regulating appetite, sexual function, inflammation and immune responses. The company’s research is centered primarily on peptide-based therapeutics designed to selectively activate specific melanocortin receptors.
Palatin’s lead commercial product is Vyleesi (bremelanotide), an injectable melanocortin-4 receptor agonist approved by the U.S.
See Also
- Five stocks we like better than Palatin Technologies
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for Palatin Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palatin Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
